← Back to Search

Other

Electrical Stimulation for Spinal Cord Injury

N/A
Waitlist Available
Led By Monica Gorassini, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Severe head injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre intervention. 1, 2 and 4 months follow up. in addition, spasticity will be measured every 2 weeks to assess stability of the effects.
Awards & highlights
No Placebo-Only Group

Summary

This trialexamines the effects of TENS on spasticity & force control in spinal cord injury. Modified Ashworth Score & pendulum test used, electrophysiological measures to assess motorneuron activity. Intervention group gets 2 months of TENS, control group 2 months later.

Who is the study for?
Adults over 18 with spinal cord injuries between the neck and mid-back (C5-T12 levels) can join this trial. It's not for those who've had a severe head injury, uncontrolled blood pressure spikes due to nerve issues (autonomic dysreflexia), or conditions that make TENS unsafe.
What is being tested?
The study is testing if lumbosacral TENS, an electrical stimulation therapy, can reduce muscle stiffness (spasticity) and improve voluntary muscle control in people with spinal cord injuries. One group gets TENS for two months; another waits two months before receiving it.
What are the potential side effects?
TENS is generally safe but may cause skin irritation under the pads, tingling sensations during use, or muscle twitching. Rarely, it might lead to discomfort or pain at the stimulation site.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a severe head injury.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre intervention. 1, 2 and 4 months follow up. in addition, spasticity will be measured every 2 weeks to assess stability of the effects.
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre intervention. 1, 2 and 4 months follow up. in addition, spasticity will be measured every 2 weeks to assess stability of the effects. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Modified Ashworth Score
Secondary study objectives
Change in EMG
Change in International Standard for Neurological Classification of SCI (ISNCSI)
Change in Knee Pendulum Angle
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Participants will receive 2 months of TENS (1 hr AM, 1 hr PM/day, 50 Hz, below pain/motor threshold, using an EMS 7500 TENS unit) immediately upon entry to the study.
Group II: Control GroupActive Control1 Intervention
Participants will not receive intervention for the first 2 months. This period will be used for comparison with the intervention group. At the end of the 2-month delay, they will receive TENS (1 hr AM, 1 hr PM/day, 50 Hz, below pain/motor threshold, using an EMS 7500 TENS unit).

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
941 Previous Clinical Trials
434,055 Total Patients Enrolled
Monica Gorassini, PhDPrincipal InvestigatorUniversity of Alberta
4 Previous Clinical Trials
58 Total Patients Enrolled

Media Library

TENS (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05103436 — N/A
Spinal Cord Injury Research Study Groups: Control Group, Intervention Group
Spinal Cord Injury Clinical Trial 2023: TENS Highlights & Side Effects. Trial Name: NCT05103436 — N/A
~17 spots leftby Dec 2026